For research use only. Not for therapeutic Use.
Didemnin B（Cat No.:I003457）is a potent cyclic depsipeptide derived from marine tunicates, crucial for advanced cancer and antiviral research. Known for its strong antitumor and antiviral properties, it inhibits protein synthesis by targeting elongation factor-1α, making it essential for studying cellular processes and developing new therapies. This high-purity compound ensures precise and reliable analytical results, supporting robust experimental setups. Ideal for investigating novel cancer treatments and antiviral agents, Didemnin B offers significant potential in the exploration of new therapeutic avenues and enhances the understanding of cellular mechanisms.
| Catalog Number | I003457 |
| CAS Number | 77327-05-0 |
| Synonyms | Didemnin B; NSC 325319; NSC-325319; NSC325319; |
| Molecular Formula | C57H89N7O15 |
| Purity | ≥95% |
| Target | Disease Research Fields |
| IUPAC Name | (2S)-N-[(2R)-1-[[(3S,6S,8S,12S,13R,16S,17R,20S,23S)-13-[(2S)-butan-2-yl]-12-hydroxy-20-[(4-methoxyphenyl)methyl]-6,17,21-trimethyl-3-(2-methylpropyl)-2,5,7,10,15,19,22-heptaoxo-8-propan-2-yl-9,18-dioxa-1,4,14,21-tetrazabicyclo[21.3.0]hexacosan-16-yl]amino]-4-methyl-1-oxopentan-2-yl]-1-[(2S)-2-hydroxypropanoyl]-N-methylpyrrolidine-2-carboxamide |
| InChI | InChI=1S/C57H89N7O15/c1-15-33(8)46-44(66)29-45(67)79-49(32(6)7)48(68)34(9)50(69)58-39(26-30(2)3)54(73)64-25-17-19-41(64)56(75)62(13)43(28-37-20-22-38(77-14)23-21-37)57(76)78-36(11)47(52(71)59-46)60-51(70)42(27-31(4)5)61(12)55(74)40-18-16-24-63(40)53(72)35(10)65/h20-23,30-36,39-44,46-47,49,65-66H,15-19,24-29H2,1-14H3,(H,58,69)(H,59,71)(H,60,70)/t33-,34-,35-,36+,39-,40-,41-,42+,43-,44-,46+,47-,49-/m0/s1 |
| InChIKey | KYHUYMLIVQFXRI-SJPGYWQQSA-N |
| SMILES | CCC(C)C1C(CC(=O)OC(C(=O)C(C(=O)NC(C(=O)N2CCCC2C(=O)N(C(C(=O)OC(C(C(=O)N1)NC(=O)C(CC(C)C)N(C)C(=O)C3CCCN3C(=O)C(C)O)C)CC4=CC=C(C=C4)OC)C)CC(C)C)C)C(C)C)O |
